Skip to content
Abametapir
Xeglyze (abametapir) is a small molecule pharmaceutical. Abametapir was first approved as Xeglyze on 2020-07-24. It is used to treat pediculus in the USA.
Download report
Favorite
FDA Novel Drug Approvals 2020
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Abametapir
Tradename
Company
Number
Date
Products
XEGLYZEHatchtech PtyN-206966 DISCN2020-07-24
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
xeglyzeNew Drug Application2020-06-05
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
pediculus—D010374—
Agency Specific
FDA
EMA
Expiration
Code
ABAMETAPIR, XEGLYZE, HATCHTECH
2025-07-24NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Abametapir, Xeglyze, Hatchtech
102923892034-12-17DPU-2863
78121632026-10-28DPU-2863
82120382024-07-16DPU-2863
93577832024-07-16DP
98396312024-07-16DS, DPU-2863
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P03: Ectoparasiticides, incl. scabicides, insecticides and repellents
— P03A: Ectoparasiticides, incl. scabicides
— P03AX: Other ectoparasiticides, incl. scabicides in atc
— P03AX07: Abametapir
HCPCS
No data
Clinical
Clinical Trials
9 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—32——5
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lice infestationsD010373B85.211———2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PediculusD0103742————2
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameABAMETAPIR
INNabametapir
Description
Abametapir is a member of bipyridines.
Classification
Small molecule
Drug classPediculicide, metalloproteinase inhibitor
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1ccc(-c2ccc(C)cn2)nc1
Identifiers
PDB—
CAS-ID1762-34-1
RxCUI—
ChEMBL IDCHEMBL2205807
ChEBI ID—
PubChem CID15664
DrugBankDB11932
UNII ID6UO390AMFB (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 22 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details